CILNIU-10

CILNIU-10 contains Cilnidipine Tablets IP 10 mg for blood pressure management in adults with hypertension when prescribed by a healthcare professional.

📋 COMPOSITION
Cilnidipine Tablets IP 10 mg

💊 DOSAGE FORM
Tablets

📦 PACKAGING TYPE
ALU-ALU

🗃️ PACKAGING
10 × 10

Description

CILNIU-10 contains Cilnidipine Tablets IP 10 mg in tablet form. Cilnidipine is a calcium channel blocker used for the management of hypertension. It works by reducing calcium entry into vascular smooth muscle cells, which helps relax blood vessels and reduce peripheral vascular resistance. CILNIU-10 may be prescribed as part of an individualized blood pressure management plan alongside appropriate lifestyle measures.

For related cardiovascular and diabetic formulations, explore the Medhexa Pharma Cardries Biotic range for additional pharmaceutical products and business enquiries.

Therapeutic Segment

Cardiovascular Therapy | Antihypertensive Therapy | Calcium Channel Blockers | Blood Pressure Management

Uses of CILNIU-10

CILNIU-10 may be prescribed as part of a treatment plan for:

  • Hypertension
  • Elevated blood pressure requiring pharmacological treatment
  • Patients requiring calcium channel blocker therapy
  • Blood pressure management when cilnidipine is considered clinically appropriate
  • Long-term blood pressure control alongside diet, exercise and other recommended lifestyle measures

The appropriate use of cilnidipine depends on the patient’s blood pressure, medical history, response to treatment and other medicines being taken.

Key Benefits of CILNIU-10

  • Blood pressure management: Helps lower elevated blood pressure by relaxing blood vessels.
  • Calcium channel blocker: Reduces calcium entry into vascular smooth muscle cells.
  • Vascular relaxation: Promotes relaxation of arterial blood vessels and reduces vascular resistance.
  • 10 mg strength: Provides a defined cilnidipine dose in tablet form.
  • Oral formulation: Convenient tablet dosage form for prescribed antihypertensive therapy.
  • Supports individualized treatment: May be used alone or with other antihypertensive medicines when clinically appropriate.

How CILNIU-10 Works

Cilnidipine belongs to the calcium channel blocker class of antihypertensive medicines.

It inhibits calcium entry through calcium channels in vascular smooth muscle. This reduces contraction of the arterial walls and promotes vasodilation.

Cilnidipine also has activity against N-type calcium channels, in addition to L-type calcium channels. N-type channel activity may reduce sympathetic nerve-mediated vascular responses.

As the blood vessels relax and vascular resistance decreases, blood pressure can fall. This mechanism allows CILNIU-10 to contribute to blood pressure control when prescribed appropriately.

Common Side Effects of CILNIU-10

Cilnidipine is generally tolerated by many patients, although side effects can occur. Possible effects include:

  • Headache
  • Dizziness
  • Flushing
  • Palpitations
  • Fatigue
  • Ankle or peripheral swelling
  • Increased heart rate
  • Low blood pressure
  • Gastrointestinal discomfort

Dizziness or light-headedness may occur when blood pressure falls more than expected, particularly after starting treatment or adjusting the dose.

Seek medical attention if you experience severe dizziness, fainting, significant swelling, breathing difficulty, chest discomfort or other concerning symptoms.

Important Safety Information

Use CILNIU-10 only according to the advice of a qualified healthcare professional.

  • Monitor blood pressure regularly as recommended by your healthcare professional.
  • Cilnidipine can lower blood pressure. Report persistent dizziness, fainting or unusual weakness.
  • Tell your doctor if you have low blood pressure, significant heart disease, liver disease or kidney problems.
  • Inform your healthcare professional about all prescription medicines, over-the-counter medicines, vitamins and supplements you take.
  • If CILNIU-10 is combined with other antihypertensive medicines, blood pressure may decrease further and monitoring may be required.
  • Avoid changing the dose or stopping treatment without medical advice.
  • Rise slowly from a sitting or lying position if you experience dizziness or light-headedness.
  • Discuss pregnancy or breastfeeding with your healthcare professional before using cilnidipine.
  • Continue appropriate dietary measures, physical activity and other lifestyle recommendations provided for blood pressure management.
  • Keep the medicine out of the reach of children.

For additional information about calcium channel blockers and hypertension management, refer to the NHS guidance on calcium channel blockers.

Dosage & Administration

Take CILNIU-10 exactly as prescribed by your healthcare professional.

The appropriate dose depends on the patient’s blood pressure, age, medical history, response to treatment and use of other antihypertensive medicines.

For cilnidipine, adult dosing is commonly individualized within the approved dosing range. A 10 mg once-daily regimen is used in some prescribing settings, with adjustments made according to blood pressure response and tolerability.

Swallow the tablet with water and follow the dosing schedule provided by your healthcare professional. It can generally be taken with or without food unless the approved product information states otherwise.

Do not increase the dose, take additional tablets or discontinue treatment without medical advice.

If you miss a dose, take it according to your healthcare professional’s instructions. Do not take a double dose to compensate for a missed tablet.

Storage

  • Store CILNIU-10 in a cool, dry place.
  • Protect the tablets from excessive heat and moisture.
  • Keep the tablets away from direct sunlight.
  • Keep the tablets in their original ALU-ALU packaging until use.
  • Keep out of the sight and reach of children.
  • Do not use the product after the expiry date printed on the packaging.

Reviews

There are no reviews yet.

Be the first to review “CILNIU-10”

Your email address will not be published. Required fields are marked *